This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Guidi, E. Articles by Hollenberg, N. K. Search for Related Content PubMed PubMed Citation Articles by Guidi, E. Articles by Hollenberg, N. K.

Hypertension, Vol 9, 591-597, Copyright © 1987 by American Heart Association

ARTICLES

Differential pressor and renal vascular reactivity to angiotensin II in spontaneously hypertensive and Wistar-Kyoto rats

E Guidi and NK Hollenberg

The suggestion has been made that the Okamoto strain of spontaneously hypertensive rats (SHR) shares some features with a subgroup of patients with essential hypertension, called nonmodulators. One feature of nonmodulators is a renal blood flow response to angiotensin II (ANG II) that is blunted on a high salt diet; the blunted renal vascular response is corrected by converting enzyme inhibition. Renal blood flow (electromagnetic flowmeter) and pressor responses to graded ANG II doses (5-300 ng) were assessed in 24 SHR and 24 Wistar-Kyoto rats (WKY) ingesting 1.6% Na. In comparison to WKY, blood pressure was higher in SHR (155 +/- 4 vs 106 +/- 2 mm Hg; p less than 0.001), renal blood flow was lower (6.9 +/- 0.5 vs 8.2 +/- 0.4 ml/min/g; p less than 0.05), and the pressor response to ANG II was enhanced, (p less than 0.0005) but the renal vascular response was blunted (p less than 0.005). Captopril (1-30 mg/kg) reduced blood pressure more in SHR than in WKY but increased renal blood flow similarly in both strains. The blunted renal vascular response to ANG II in SHR was reversed by captopril, but inhibition of converting enzyme in the kidney did not parallel systemic inhibition. Maximum blockade of converting enzyme in the kidney appears to require a larger captopril dose than is required for systemic inhibition. These results suggest that the renal blood supply in SHR also shares some of the characteristics of nonmodulators and that the action of captopril on the renal blood flow probably reflects reversal of inappropriate intrarenal ANG II formation.

This article has been cited by other articles:

				M C. Lansang, S. Y Osei, C. Coletti, J. Krupinski, and N. K Hollenberg Hyperglycaemia-induced intrarenal RAS activation: the contribution of metabolic pathways Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1): 19 - 23. [Abstract] [PDF]

				R. Mokkapatti, S. J. Vyas, and E. K. Jackson G protein mRNA expression in renal microvessels from spontaneously hypertensive and Wistar-Kyoto rats Am J Physiol Renal Physiol, December 1, 1997; 273(6): F877 - F882. [Abstract] [Full Text] [PDF]